Signatope GmbH

Signatope GmbH

Biotechnology-Research

55, Hauptsitz
Industry Category
Biotechnology-Research
Company Description

Signatope GmbH is a pioneering biotechnology research company dedicated to advancing the field through innovative protein biomarker assays. Utilizing cutting-edge immunoaffinity-based mass spectrometry, Signatope GmbH develops next-generation assays applicable to both human samples and pharmacologically relevant model species.

Based in Markwiesenstraße 55, Hauptsitz, DE, Signatope GmbH is committed to providing solutions that drive progress in research and development. The company's focus on precision and comprehensive coverage ensures reliable and impactful results for its partners.

Signatope GmbH is poised for continued growth and success in the biotechnology sector. We invite the management of Signatope GmbH to create a customized and exclusive company showcase and product listing on our platform, enhancing their visibility and commercial opportunities.

Key Personnel / Employees
Dr. Lena-Sophie Schütter Hannes Planatscher Helen Hammer Oliver Pötz

Similar Companies

Other organizations in the same industry

Anzo Bio
Biotechnology-Research

Decoding Health, Delivering Hope

GrittGene Therapeutics
Biotechnology-Research

For Myotonic Dystrophy Type 2, we develop the cure of tomorrow by combining all the tools available...

Glendale, California
United States
BrilliantStrings Therapeutics
Biotechnology-Research

Helping patients with orthopedic injuries

Boston, MA
United States
Sanavia Oncology Inc.
Biotechnology-Research

Science for the benefit of patients

New York, NY
United States

Alternative Company Names

This company is also known as

Signatope GmbH सिग्नाटोप जीएमबीएच سيجناتوب جي إم بي إتش Сигнатопе ГмбХ